Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Chappell

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Science Translational Medicine|July 31, 2020
Cellular senescence impairs the reversibility of pulmonary arterial hypertensionDiederik E van der Feen, Guido P L Bossers, Quint A J Hagdorn, et al.
JAMA Pediatrics|September 22, 2015
Epidemiologic Association Between FUT2 Secretor Status and Severe Rotavirus Gastroenteritis in Children in the United StatesDaniel C Payne, Rebecca L Currier, Mary A Staat, et al.
Circulation|August 30, 2019
Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal TransformationWen Tian, Xinguo Jiang, Yon K Sung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2024
Seasonality, Clinical Characteristics, and Outcomes of Respiratory Syncytial Virus Disease by Subtype Among Children Aged <5 Years: New Vaccine Surveillance Network, United States, 2016-2020Ariana P Toepfer, Justin Z Amarin, Andrew J Spieker, et al.
The Pediatric Infectious Disease Journal|October 17, 2025
Nirsevimab is Effective Against Respiratory Syncytial Virus-Associated Hospitalization Among American Indian and Alaska Native Children in Their First and Second RSV Seasons in Alaska and the Southwest United States, 2023-2024Laura L Hammitt, Joel S Espinoza, James W Keck, et al.
The Pediatric Infectious Disease Journal|March 10, 2026
Nirsevimab is Effective Against Respiratory Syncytial Virus-Associated Hospitalization Among American Indian and Alaska Native Children in Their First and Second RSV Seasons in Alaska and the Southwest United States, 2023-2024: ErratumLaura L Hammitt, Joel S Espinoza, James W Keck, et al.
JAMA Network Open|October 22, 2025
Changes in Antiviral Prescribing for Children With Influenza in US Emergency DepartmentsTess Stopczynski, Olla Hamdan, Justin Z Amarin, et al.
JAMA Network Open|September 28, 2019
Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016Daniel C Payne, Janet A Englund, Geoffrey A Weinberg, et al.
Influenza and Other Respiratory Viruses|June 11, 2025
Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016-2020Tess Stopczynski, Justin Z Amarin, James W Antoon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2013
Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011Daniel C Payne, Julie A Boom, Mary Allen Staat, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Science Translational Medicine|July 31, 2020
Cellular senescence impairs the reversibility of pulmonary arterial hypertensionDiederik E van der Feen, Guido P L Bossers, Quint A J Hagdorn, et al.
JAMA Pediatrics|September 22, 2015
Epidemiologic Association Between FUT2 Secretor Status and Severe Rotavirus Gastroenteritis in Children in the United StatesDaniel C Payne, Rebecca L Currier, Mary A Staat, et al.
Circulation|August 30, 2019
Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal TransformationWen Tian, Xinguo Jiang, Yon K Sung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2024
Seasonality, Clinical Characteristics, and Outcomes of Respiratory Syncytial Virus Disease by Subtype Among Children Aged <5 Years: New Vaccine Surveillance Network, United States, 2016-2020Ariana P Toepfer, Justin Z Amarin, Andrew J Spieker, et al.
The Pediatric Infectious Disease Journal|October 17, 2025
Nirsevimab is Effective Against Respiratory Syncytial Virus-Associated Hospitalization Among American Indian and Alaska Native Children in Their First and Second RSV Seasons in Alaska and the Southwest United States, 2023-2024Laura L Hammitt, Joel S Espinoza, James W Keck, et al.
The Pediatric Infectious Disease Journal|March 10, 2026
Nirsevimab is Effective Against Respiratory Syncytial Virus-Associated Hospitalization Among American Indian and Alaska Native Children in Their First and Second RSV Seasons in Alaska and the Southwest United States, 2023-2024: ErratumLaura L Hammitt, Joel S Espinoza, James W Keck, et al.
JAMA Network Open|October 22, 2025
Changes in Antiviral Prescribing for Children With Influenza in US Emergency DepartmentsTess Stopczynski, Olla Hamdan, Justin Z Amarin, et al.
JAMA Network Open|September 28, 2019
Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016Daniel C Payne, Janet A Englund, Geoffrey A Weinberg, et al.
Influenza and Other Respiratory Viruses|June 11, 2025
Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016-2020Tess Stopczynski, Justin Z Amarin, James W Antoon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2013
Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011Daniel C Payne, Julie A Boom, Mary Allen Staat, et al.
Pageof 10